1. Li X, Sundquist K, Jansåker F. Fluoroquinolones and other antibiotics redeemed for cystitis – A Swedish Nationwide Cohort Follow-Up study (2006–2018). Antibiotics 2022; 11: 172.
2.
Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin N Am 2008; 35: 1–12.
3.
Gupta K, Hooton TM, Naber KG, et al. Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103–e120.
4.
Philips H, Huibers L, Holm Hansen E, et al. Guidelines adherence to lower urinary tract infection treatment in out-of-hours primary care in European countries. Qual Prim Care 2014; 22: 221–231.
5.
ESAC-Net. Distribution of antimicrobial consumption by antimicrobial group. Antimicrobial-consumption/database/distribution-by-antimicrobial group [cited 20.12.2021]. Available from URL: https://ecdc.europa.eu/en/.
6.
Versporten A, Bolokhovets G, Ghazaryan L, et al. WHO/Europe-ESAC Project Group. Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis 2014; 14(5): 381–387, doi: 10.1016/S1473-3099(14)70071-4.
7.
Córdoba G, Holm A, Hansen F, et al. Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark. BMC Infectious Diseases 2017; 17: 670.
8.
Stewardson AJ, Vervoort J, Adriaenssens N, et al. Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study. Clin Microbiol Infect 2018; 24: 972–979.
9.
Dahlhoff A. Resistance surveillance studies: a multifaceted problem – the fluoroquinolone example. Infection 2012; 40: 239–262.
10.
Huttner A, Verhaegh EM, Harbarth S, et al. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother 2015; 70: 2456–2464.
11.
Cunha BA. New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited. Med Clin N Am 2006; 60: 1089–1107.
12.
Škerk V, Tambić Andrašević A, Sušić E. Dopune i promjene ISKRA hrvatskih nacionalnih smjernica za liječenje i profilaksu infekcija mokraćnog sustava odraslih. Infektol Glasnik 2014; 34: 177–181 (in Croatian).
13.
Philips H, Huibers L, Holm Hansen E, et al. Guidelines adherence to lower urinary tract infection treatment in out-of-hours primary care in European countries. Qual Prim Care 2014; 22: 221–231.
14.
Martínez MA, Inglada L, Ochoa C, et al. Spanish Study Group on Antibiotic Treatments. Assessment of antibiotic prescription in acute urinary tract infections in adults. J Infect 2007; 54: 235–244.
15.
Škerk V, Škerk V, Jakšić J, et al. Research of urinary tract infections in family medicine physicians’ offices – empiric antimicrobial therapy of urinary tract infections – Croatian experience. Coll Antropol 2009; 33: 625–631.
16.
Radošević Quadranti N, Vlahović-Palčevski V, Popović B, et al. Impact of guidelines on antibiotic prescribing approach in primary care – a 10-year study. Fam Pract 2021; 38: 259–264.
17.
Agency for Medicinal Products and Medical Devices of Croatia. Annual Report on Drug Consumption for 2018 – Croatian document [cited 20.01.2025]. Available from URL: http://halmed.hr/Novosti-i-edukacije/Publikacije-i-izvjesca/Izvjesca-o-potrosnji-lijekova/Izvjesce-o-potrosnji-lijekova-u-Republici-Hrvatskoj-u-2018/.
18.
Tambić Andrašević A, Tambić T, eds. Antibiotic Resistance in Croatia. 2018. Zagreb: The Croatian Academy of Medical Sciences; 2019.
19.
Adriaenssens N, Coenen S, Tonkin-Crine S, et al. The ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf 2011; 20: 764–772.
20.
Stuck AK, Tauber MG, Schabel M, et al. Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection. Antimicrob Agents Chemother 2012; 56: 1359–1363.
21.
Palin V, Mölter A, Belmonte M, et al. Antibiotic prescribing for common infections in UK general practice: variability and drivers. J Antimicrob Chemother 2019; 74: 2440–2450.
22.
Dolk FCK, Pouwels KB, Smith DRM, et al. Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions? J Antimicrob Chemother 2018; 73(Suppl. 2): ii2–ii10.
23.
Robertson J, Vlahović-Palčevski V, Iwamoto K, et al., ESAC-Net Study Group; WHO Europe AMC Network Study Group. Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe. Front Pharmacol 2021; 12: 639207, doi: 10.3389/fphar.2021.639207.
24.
Tyrstrup M, Velden A, van der, Engstrom S, et al. Antibiotic prescribing in relation to diagnoses and consultation rates in Belgium, the Netherlands and Sweden: use of European quality indicators. Scand J Prim Health Care 2017; 35(1): 10–18, doi: 10.1080/02813432.2017.1288680.
25.
Glinz D, Leon Reyes S, Saccilotto R, et al. Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey. J Antimicrob Chemother 2017; 72(11): 3205–3212, doi: 10.1093/jac/dkx278.
26.
Ljung R, Reimers A, Ericsson O, et al. Inequality in quality? Regional and educational differences in treatment with fluoroquinolone in urinary tract infection of 236,376 Swedish patients. BMJ Qual Saf 2011; 20(1): 9–14, doi: 10.1136/bmjqs.2008.028696.
27.
Jovanović A, Stevanović R, Pristaš I, et al. Učestalost, dijagnostika i liječenje infekcija mokraćnog sustava u ordinacijama obiteljske medicine. Medicus 2006; 15(2): 339–344 (in Croatian).
28.
Vellinga A, Cormican M, Hanahoe B, et al. Bennett K, Murphy AW. Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland. BMC Family Practice 2011; 12: 108.
29.
Llor C, Rabanaque G, López A, et al. The adherence of GPs to guidelines for the diagnosis and treatment of lower urinary tract infections in women is poor. Fam Pract 2011; 28: 294–299.
30.
Llor C, Bjerrum L. Background for different use of antibiotics in different countries. Clin Infect Dis 2005; 40: 333.
31.
Lopez-Vazquez P, Vazquez-Lago JM, Figueiras A. Misprescription of antibiotics in primary care: a critical systematic review of its determinants. J Eval Clin Pract 2012; 18: 473–484.
32.
Butler CC, Dunstan F, Heginbothom M, et al. Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract 2007; 57: 785–792.
33.
Dalhoff A. Global fluoroquinolone resistance epidemiology and implications for clinical use. Interdiscip Perspect Infect Dis 2012; 2012: 976273.
34.
Cormican M, Vellinga A. Existing classes of antibiotics are probably the best we will ever have. BMJ 2012; 344: e3369, doi: 10.1136/bmj.e 3369.
